| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 06/29/2006 | WO2006067330A1 Pharmaceutical compositions based on fluorinated sulphamides and sulphinimides |
| 06/29/2006 | WO2006066354A1 Formula ions and treatments for well-being |
| 06/29/2006 | US20060142289 Method of treating migraine headaches |
| 06/29/2006 | US20060142258 Estrogen replacement therapy |
| 06/29/2006 | US20060142254 Antipyretic preparation containing xylitol |
| 06/29/2006 | US20060141080 Extracting crushed plant material Cuminum cyminum with water or 50% aqueous alcoholic solvent; extracting a portion of the aqueous extract with n-butanol, separating -butanol layer and an aqueous layer, evaporating, and freeze drying the aqueous layer |
| 06/29/2006 | US20060140931 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 06/29/2006 | US20060137207 Flavonoid compounds as therapeutic antioxidants |
| 06/29/2006 | CA2634953A1 Formulations and treatments for well-being |
| 06/29/2006 | CA2592121A1 Methods for use of oral care compositions containing free-b-ring flavonoid anti-oxidants |
| 06/28/2006 | EP1267901B9 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress |
| 06/28/2006 | CN1794982A Use of compounds for the prevention of drug-induced cell toxicity |
| 06/28/2006 | CN1793136A Process for producing kuh-seng total flavone and flavone salt |
| 06/28/2006 | CN1793135A Process for producing kuh-seng total flavone and flavone salt by kuh-seng |
| 06/28/2006 | CN1792366A Ginkgo leaves dispersion tablets, and its preparing method |
| 06/28/2006 | CN1792250A Nutrient food for reducing-weight, preventing and treating fatty liver disease, and its prodn. method |
| 06/28/2006 | CN1792209A Fructus ligustri lucidi health-care tea, and its prepn. method |
| 06/28/2006 | CN1261416C Perfuoroalkylamide, prodn. and use in diagnostics thereof |
| 06/28/2006 | CN1261141C Medicine prepn for preventing and retarding side effect of chemotherapy and its prepn process |
| 06/28/2006 | CN1261093C Use of glutaraldehyde in preparing medicine for preventing animal toxic diseases |
| 06/28/2006 | CN1261045C Anti-oxidation health-care food and its production method |
| 06/27/2006 | US7067524 estrogen receptor agaonists or antagonists; therapy or prophylaxis for endometriosis; 8-fluoro-6-(3-fluoro-4-hydroxyphenyl)-2-naphthol |
| 06/27/2006 | US7067158 Preparation for the relief of disease |
| 06/22/2006 | WO2006064686A1 Drug and method for preventing or relieving delayed nerve cell death |
| 06/22/2006 | US20060135587 Method and compounds for promoting healing and reducing inflammation |
| 06/22/2006 | US20060135521 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 06/22/2006 | US20060135520 Method of treating peripheral neuropathy |
| 06/22/2006 | US20060134249 proanthocyanidin from hops; detoxification a toxicity from germs causing infectious disease |
| 06/22/2006 | US20060134095 Antioxidative composition and composition for external use |
| 06/22/2006 | US20060134085 Compositions containing coenzyme q10 |
| 06/21/2006 | EP1670485A1 Treatment of diseases associated with the egr-1 enhancer element |
| 06/21/2006 | EP1670469A1 Use of known active ingredients as radical scavengers |
| 06/21/2006 | EP1450781B1 Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 06/21/2006 | CN1791408A Treatment of neurological conditions |
| 06/21/2006 | CN1788767A 'Jiushendan' for fighting against senium |
| 06/21/2006 | CN1788744A Ciliate desert-grass effective parts formulation resin processing method |
| 06/21/2006 | CN1259925C Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use |
| 06/21/2006 | CN1259923C Adsorbent for endocrine disruptors and foods and drinks containing the same |
| 06/21/2006 | CN1259851C Extractive product of sunflower |
| 06/20/2006 | US7064119 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence |
| 06/20/2006 | US7064112 selectively inhibiting abnormal cell proliferation by administering an A3-selective adenosine A3 receptor agonist in an amount of less than 100 mu g/Kg body weight. |
| 06/15/2006 | WO2006062110A1 Piperazine derivative |
| 06/15/2006 | WO2006042479A9 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 06/15/2006 | US20060128705 Method of treating chronic fatigue syndrome |
| 06/15/2006 | US20060128678 Manganese based organometallic complexes, pharmaceutical compositions and dietetic products |
| 06/15/2006 | US20060128672 Methods for the administration of amifostine and related compounds |
| 06/15/2006 | US20060128656 Charged phospholipid compositions and methods for their use |
| 06/15/2006 | US20060127508 Preparation for the relief of disease |
| 06/15/2006 | US20060127378 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 06/14/2006 | EP1669462A1 Method of preparing alpha-glycosylisoquercitrin, intermediate therefor and by-product |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1381373B1 Medical compositions for use in the treatment or prevention of a functional vitamin b12 deficienfcy |
| 06/14/2006 | EP1341770B1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors |
| 06/14/2006 | EP1285661B1 Use of an antioxidant comprising an extract of mozuku |
| 06/14/2006 | EP1157704B1 Spla2 inhibitors for the treatment of ischaemic reperfusion injury |
| 06/14/2006 | DE102004059024A1 Preparation of immunostimulation factor, useful to treat cancer and stimulate immune system, comprises treating the blood of a cancer patient with ultrasound and centrifuging, where both steps are carried out at specific conditions |
| 06/14/2006 | CN1785971A Benzoin kind lean uranium discharging promotor, its preparation method and use |
| 06/14/2006 | CN1785949A Calixarene kind lean uranium discharge prometor, its preparation method and use |
| 06/14/2006 | CN1785401A Chinese medicine for antisenility and its preparation method |
| 06/14/2006 | CN1785309A Chinese herbal medicine oral liquid for face nourishing antidebilitation and its preparation method |
| 06/14/2006 | CN1785218A Extractive of pomegranate seeds, prepn. method and application in preparing medicine thereof |
| 06/14/2006 | CN1785204A Baicalin freeze-drying powder for injection use and its prepn. method |
| 06/14/2006 | CN1785201A Panaxsaponin composition, prepn. method and use thereof |
| 06/14/2006 | CN1785200A Notogisennoside composition, prepn. method and application thereof |
| 06/14/2006 | CN1785165A Oral disintegrant tablets of beta-carotene and its prepn. method |
| 06/14/2006 | CN1259339C Genetically engineering monoclonal anti-digoxin single-stranded antibody and its use |
| 06/14/2006 | CN1259316C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 06/14/2006 | CN1259032C Cosmetic or dermatological preparation for avoiding skin damage caused by peroxide |
| 06/13/2006 | US7060802 Monoclonal antibody hybridomas ; detecting cancer |
| 06/08/2006 | WO2006059730A1 Composition for body fat reduction |
| 06/08/2006 | US20060122374 Albumin-fused anti-angiogenesis peptides |
| 06/07/2006 | EP1666445A1 Reduced coenzyme q sb 10 /sb crystal excelling in stability and composition containing reduced coenzyme q10 crystal |
| 06/07/2006 | EP1666092A2 Drug combination comprising a fatty acid and a uridine compound. |
| 06/07/2006 | EP1666028A1 Dry powder compositions having improved dispersivity |
| 06/07/2006 | EP1663268A1 Oral compositions and route of administration for the delivery of a thylakoid extract |
| 06/07/2006 | EP1663244A2 Pteridine derivatives for the treatment of septic shock and tnf-alpha-related diseases. |
| 06/07/2006 | EP1663203A1 Pharmaceutical compositions for the treatment of organophosphate poisoning |
| 06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
| 06/07/2006 | EP1017789B1 Nucleic acid encoding a lectin-derived progenitor cell preservation factor |
| 06/07/2006 | CN1781545A Method for extracting herbal medicine |
| 06/06/2006 | US7057076 which have improved receptor binding affinity via substituted alkyl side chains at the c-3 position; may contain terpene funtionality combined with resorcinol moieties; for treatment of nervous system disorders and cardiovascular disorders |
| 06/06/2006 | US7056938 Method for scavenging radicals with urocanic acid, derivatives and analogues |
| 06/01/2006 | WO2006031337A3 Combinations of pkc activators and pkc inhibitors for alzheimer’s disease treatment and cognitive enhancement |
| 06/01/2006 | US20060115542 Therapeutic delivery of carbon monoxide |
| 05/31/2006 | EP1661564A1 Heterocyclic compounds and their pharmaceutical use |
| 05/31/2006 | EP1328282B1 Efficient method for producing compositions enriched in anthocyanins |
| 05/31/2006 | CN1778373A Health-care composition |
| 05/31/2006 | CN1257710C Preparation made from effective position of red sage root, and its preparation method |
| 05/30/2006 | US7053072 Methods for the administration of amifostine and related compounds |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7052896 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 05/30/2006 | CA2375908C Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 05/26/2006 | WO2006055412A1 Methods of treating erythropoietin-resistance |
| 05/26/2006 | WO2006053379A1 Improved nutraceutical composition |
| 05/26/2006 | CA2587558A1 Methods of treating erythropoietin-resistance |
| 05/25/2006 | US20060111419 Novel fused indazole compounds |
| 05/25/2006 | US20060110520 Active oxygen eliminator derived from natural substance and use thereof |
| 05/25/2006 | US20060110474 Rubrofusarin glycoside-containing composition |
| 05/25/2006 | US20060110465 Compositions addressing inflammation and/or degenerative disorders |
| 05/25/2006 | US20060110446 Deferacirox dispersible tablets |